Alcoholic ketoacidosis evaluated with a point-of-care capillary beta-hydroxybutyrate measurement device

被引:1
|
作者
Nishizawa, Takuya [1 ,2 ]
Matsumoto, Takashi [1 ]
Todaka, Takafumi [1 ]
Sasano, Mikio [1 ]
机构
[1] Nakagami Hosp, Dept Intens Care Med, 610 Noborikawa, Okinawa, Okinawa 9042195, Japan
[2] 641-7 Miyazato, Uruma, Okinawa 9042243, Japan
关键词
Alcoholic ketoacidosis; Beta-hydroxybutyrate; Point -of -care capillary beta; hydroxybutyrate measurement device; Emergency department; DIABETIC-KETOACIDOSIS; MULTIPLE COMPLICATIONS; METABOLIC-ACIDOSIS; DIAGNOSIS; DEATH;
D O I
10.1016/j.alcohol.2023.06.005
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The diagnosis of alcoholic ketoacidosis (AKA) has traditionally been made based only on clinical history and the presence of severe metabolic acidosis with a high anion gap (AG); however, the concentration of beta-hydroxybutyrate (BOHB), a pivotal ketone body in AKA, is not evaluated in most cases. The aim of this study was to clarify the clinical spectrum of AKA in terms of the severity of ketoacidosis by using a point-of-care capillary BOHB measurement device.Methods: This retrospective case series was conducted at a Japanese private teaching hospital. Patients with suspected AKA, based on their clinical history, who underwent BOHB measurement using a point -of-care capillary measurement device in the emergency department, were included. Data on their clinical presentations, blood tests, and treatments were collected, described, and compared between patients with a BOHB concentration higher than 3.0 mmol/L (H-BOHB) and those with a concentration less than 3.0 mmol/L (L-BOHB).Results: A total of 83 patients were included in this study. Sixty-eight patients were categorized as having H-BOHB and 15 as having L-BOHB. Nausea (71%), vomiting (71%), tachycardia (76%), and tachypnea (46%) were commonly observed at presentation. Hyponatremia (46%), hypokalemia (34%), hypomagnesemia (42%), and hyperphosphatemia (41%) were frequent electrolyte abnormalities upon presentation. Rehydration with balanced crystalloids and glucose-containing intravenous fluids, electrolyte supplementation, and thiamine replacement were the major treatments. The mean length of stay in the ICU and hospital were 4.4 and 7.0 days, respectively, with low overall mortality (1%). The H-BOHB and L-BOHB groups did not differ in terms of clinical data. Seventy percent of patients with L-BOHB had severe metabolic acidosis with a high AG due to hyperlactatemia (mean lactate concentration: 8.5 mmol/L).Conclusions: We described the clinical features of AKA measured by using a point-of-care capillary BOHB measurement device. Although certain patients diagnosed with AKA based only on their clinical history had predominant lactic acidosis with minor elevations in BOHB concentration, the BOHB concentration had no effect on the clinical spectrum of AKA in this study.& COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [41] Diagnostic Accuracy of Point-of-Care Testing for Diabetic Ketoacidosis at Emergency-Department Triage β-Hydroxybutyrate versus the urine dipstick
    Arora, Sanjay
    Henderson, Sean O.
    Long, Theodore
    Menchine, Michael
    DIABETES CARE, 2011, 34 (04) : 852 - 854
  • [42] SIMULTANEOUS MEASUREMENT OF KETONE-BODIES - ACETOACETATE (ACAC) AND BETA-HYDROXYBUTYRATE (BHB)
    NUWAYHID, NF
    JOHNSON, GF
    FELD, RD
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1175 - 1175
  • [43] Role of beta-hydroxybutyrate measurement in the evaluation of plasma glucose concentrations in newborn infants
    Stanley, Charles A.
    Weston, Philip J.
    Harris, Deborah L.
    De Leon, Diva D.
    Harding, Jane E.
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2024, 109 (06): : 580 - 585
  • [44] Point-of-care device: a word of caution
    Bhagwat, A. G.
    Taneja, S.
    Singal, N.
    Narang, S.
    ANAESTHESIA AND INTENSIVE CARE, 2009, 37 (01) : 138 - 139
  • [45] Evaluating agreement between separate capillary sampling sites and venous concentrations of β-hydroxybutyrate measured by a point-of-care device and liquid chromatography tandem mass spectrometry
    Bjerg, Lise Norkjaer
    Thomsen, Henrik Holm
    Sandfeld-Paulsen, Birgitte
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2025,
  • [46] A Paper-Based "Pop-up" Electrochemical Device for Analysis of Beta-Hydroxybutyrate
    Wang, Chien-Chung
    Hennek, Jonathan W.
    Ainla, Alar
    Kumar, Ashok A.
    Lan, Wen-Jie
    Im, Judy
    Smith, Barbara S.
    Zhao, Mengxia
    Whitesides, George M.
    ANALYTICAL CHEMISTRY, 2016, 88 (12) : 6326 - 6333
  • [47] Point-of-care measurement of fetal blood lactate - Time to trust a new device
    Wang, Mandy
    Chua, Seng C.
    Bouhadir, Lilain
    Treadwell, Erin L.
    Gibbs, Emma
    McGee, Therese M.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2018, 58 (01): : 72 - 78
  • [48] How to accredit bedside total hemoglobin measurement with the HemoCue® point-of-care device?
    Augis, Vanessa
    Weinmann, Laurent
    Castaing-Mouhica, Gladys
    Terral, Catherine
    Berthon, Nathalie
    Pujol, Sophie
    Beauvieux, Marie-Christine
    ANNALES DE BIOLOGIE CLINIQUE, 2021, 79 (02) : 196 - 202
  • [49] New point-of-care test identifies diabetic ketoacidosis in triage
    Naunheim, RS
    Jang, TB
    Chu, MB
    McGill, JB
    Kryder, G
    Scott, MG
    Hock, KG
    Banet, GA
    Walker, MS
    ANNALS OF EMERGENCY MEDICINE, 2004, 44 (04) : S78 - S79
  • [50] Postmortem Diagnosis of Ketoacidosis by Determining Beta-Hydroxybutyrate Levels in Three Types of Body Fluids by Two Different Methods
    Iliescu, Diana Bulgaru
    Furnica, Cristina
    Girlescu, Nona
    Chistol, Raluca Ozana
    Perianu, Lacramioara
    Diac, Madalina
    Timofte, Andrei Daniel
    Knieling, Anton
    Ciureanu, Ioan-Adrian
    APPLIED SCIENCES-BASEL, 2022, 12 (11):